May 22 2026

Surprising study finds beef doesn’t worsen blood sugar or diabetes risk

A new clinical trial suggests that eating beef every day may not be as risky for people with prediabetes as many assume. Researchers found that adults who ate 6–7 ounces of beef daily for a month showed no worsening in blood sugar control, insulin function, inflammation, or other key markers linked to type 2 diabetes when compared to people eating poultry instead.

Read More

From Science Daily • • 0

May 22 2026

Scientists discover simple way to relieve arthritis pain without pills or surgery

A surprisingly simple walking tweak may offer new hope for millions living with knee osteoarthritis. In a year-long clinical trial, researchers found that slightly changing the angle of a person’s foot while walking reduced knee pain as effectively as common medications — and even slowed cartilage damage inside the joint.

Read More

From Science Daily • • 0

May 22 2026

Popular weight loss drugs like Wegovy may also target arthritis inflammation

Researchers have discovered that the GLP-1 hormone targeted by drugs like Wegovy is present in very low amounts inside the joints of arthritis patients. That finding suggests high-dose GLP-1 medications could potentially reach the joints and influence inflammation directly, not just help through weight loss. Scientists say this could open the door to a completely new approach to arthritis treatment.

Read More

From Science Daily • • 0

May 21 2026

Scientists discover a two-stage aging process that may cause cancer and arthritis

A new theory suggests many age-related diseases may actually start decades before symptoms appear. Researchers say early-life damage — from infections, injuries, or genetic mutations — can remain hidden until aging weakens the body’s ability to keep it under control. This could explain why conditions like cancer, osteoarthritis, and shingles suddenly emerge later in life.

Read More

From Science Daily • • 0

May 21 2026

Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk

A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Researchers say these medications could become a major weapon against cardiovascular disease — not just obesity and diabetes.

Read More

From Science Daily • • 0